Biomerica (BMRA) Free Cash Flow Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Biomerica | 7.12 Mn | 5.78 Mn | -44,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | 2.37% |
| Nov 30, 2025 | 5.36% |
| Aug 31, 2025 | 30.36% |
| May 31, 2025 | 28.35% |
| Feb 28, 2025 | -17.92% |
| Nov 30, 2024 | -16.92% |
| Aug 31, 2024 | -164.79% |
| May 31, 2024 | -1.03% |
| Feb 29, 2024 | -45.47% |
| Nov 30, 2023 | -26.73% |
| Aug 31, 2023 | -16.36% |
| May 31, 2023 | -20.56% |
| Feb 28, 2023 | -27.68% |
| Nov 30, 2022 | -35.42% |
| Aug 31, 2022 | -61.85% |
| May 31, 2022 | -66.58% |
| Feb 28, 2022 | 77.17% |
| Nov 30, 2021 | -65.09% |
| Aug 31, 2021 | 24.43% |
| May 31, 2021 | -96.62% |
| Feb 28, 2021 | -56.82% |
| Nov 30, 2020 | -38.94% |
| Aug 31, 2020 | -52.06% |
| May 31, 2020 | -108.70% |
| Feb 29, 2020 | 1.84% |
| Nov 30, 2019 | -65.01% |
| Aug 31, 2019 | -15.70% |
| May 31, 2019 | -103.26% |
| Feb 28, 2019 | -13.58% |
| Nov 30, 2018 | 9.99% |
| Aug 31, 2018 | -15.60% |
| May 31, 2018 | -28.08% |
| Feb 28, 2018 | -19.80% |
| Nov 30, 2017 | -19.67% |
| Aug 31, 2017 | -20.55% |
| May 31, 2017 | -89.19% |
| Feb 28, 2017 | -20.63% |
| Nov 30, 2016 | -41.51% |
| Aug 31, 2016 | -24.98% |
| May 31, 2016 | -16.78% |
| Feb 29, 2016 | 51.63% |
| Nov 30, 2015 | -25.79% |
| Aug 31, 2015 | 0.43% |